Alexza Pharma (ALXA) Posts Q4 GAAP EPS of $0.42
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Join SI Premium – FREE
Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) reported Q4 GAAP EPS of $0.42, which may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $20.88 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Paramount Global (PARA) Tops Q2 EPS by 480c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
